Literature DB >> 489497

Activity of antimicrobials against Chlamydia trachomatis in vitro.

G L Ridgway, J D Oriel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 489497     DOI： 10.1093/jac/5.4.483

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Dose ranging study of cefpimizole (U-63196E) for treatment of uncomplicated gonorrhea in men.

Authors:  E T Sandberg; P S Pegram; R E Roddy; H H Handsfield; K D Hampton; K M Shafran; E W Hook
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.

Authors:  R Cevenini; V Sambri; M La Placa
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

3.  Antibacterial activity of DL 473, a C3-substituted rifamycin derivative.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 4.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  M R Hammerschlag; A Gleyzer
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

Review 7.  Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.